Sidecar Health Valuation, Funding & Investors

Sidecar Health is valued at $1B as of January 2021.

Last Sidecar Health valuation

$1B

Series C · Jan 2021

Last Sidecar Health funding round

$165M

Series D · Jun 2024

Cumulative funding Sidecar Health raised

$328M

across 4 funding rounds

Key investors in Sidecar Health

  • GreatPoint Ventures
  • Cathay Innovation
  • Morpheus Ventures
  • Menlo Ventures
  • Drive Capital
  • Bond

Sidecar Health Overview

About Sidecar Health

Sidecar Health is a San Francisco-headquartered health insurer that delivers plans without provider networks, prior authorizations, or referrals. Members access any doctor nationwide and pay via a dedicated Visa card, retaining half of savings if spending falls below their annual allowance. The company operates in California, Texas, and Oklahoma, displaying coverage details upfront to encourage cost-aware decisions. Sidecar Health reports fewer than 1% denied clinical claims, prioritizing member control over traditional insurer gatekeeping.


Founded

2018

HQ

United StatesLos Angeles, CA

Status

Privately held

Customer focus

B2C

Revenue model

Product sales

Valuation

$1B (Jan 2021)

Sidecar Health Valuation

Sidecar Health is currently valued at $1B, based on its Series C in January 2021.

The $125M round was led by Drive Capital, with participation from GreatPoint Ventures, Menlo Ventures, Alpha Edison, Tiger Global, Cathay Innovation and 1 other investor.

Sidecar Health valuation by funding round

Sidecar Health valuation by funding round
DateStageValuation
Jan 2021Series C$1B

Sidecar Health Funding History

Sidecar Health has raised a total of $328M across 4 funding rounds.

Sidecar Health's first fundraising round was a $18M undisclosed-stage round in August 2019. The most recent completed round was a $165M Series D in June 2024.

Sidecar Health funding rounds

Sidecar Health funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Jun 2024Series DKoch Disruptive Technologies (lead); GreatPoint Ventures; Menlo Ventures; Marbruck; Morpheus Ventures; Drive Capital; Duke University; Cathay Innovation; Bond$165M-Sidecar Health is a health insurance company offering major medical coverage to businesses with a model centered on price transparency, allowing members to know exact plan payments before care, shop providers using a VISA card for direct payments, and share savings when choosing lower-cost providers. The company eliminates coinsurance, copays, prior authorizations, and restrictive networks, enabling access to any doctor based on self-pay rates and quality scores. Founded in 2018, Sidecar Health previously achieved unicorn status and operates employer plans in states like Ohio, Georgia, and plans to expand into Florida and Texas. On June 26, 2024, Sidecar Health closed a $165 million Series D financing round, described as the largest private investment in employer health benefits that year. Koch Disruptive Technologies led the round, with participation from new and existing investors including GreatPoint Ventures, BOND, Cathay Innovation, Drive Capital, Duke University, Menlo Ventures, and Morpheus Ventures. The funding supports geographic expansion into Florida's jumbo employer market, where 1.4 million people are covered by large employers, and further commercial growth. In addition to the investment, Koch Industries—a conglomerate with subsidiaries like Georgia-Pacific providing health coverage to over 100,000 employees—selected Sidecar Health's major medical insurance for a segment of its 2025 workforce and partnered as a design collaborator for jumbo employer plans. This strategic alliance underscores Sidecar Health's push into large-scale employer-sponsored insurance, addressing frustrations with traditional plans amid rising U.S. healthcare costs projected to reach $5 trillion annually. The model promotes a consumer-driven, free-market approach to counter systemic inefficiencies in access, cost, and outcomes.
Jan 2021Series CDrive Capital (lead); GreatPoint Ventures; Menlo Ventures; Alpha Edison; Tiger Global; Cathay Innovation; Bond$125M$1BSidecar Health is a health insurtech company founded in 2018 that uses a "cash price" model enabling members to pay lower self-pay prices to healthcare providers rather than rates negotiated by traditional insurance companies. The company aims to eliminate $1 trillion in healthcare waste annually by bringing transparency and consumer behavior to the opaque US healthcare market. In January 2021, Sidecar Health announced a $125 million Series C funding round at a $1 billion post-money valuation, becoming a unicorn. The round was led by Drive Capital and included new investors BOND, Tiger Global, and Menlo Ventures, along with existing investors Cathay Innovation and GreatPoint Ventures. By this time, the company had raised over $175 million since its founding. The capital was planned to accelerate growth and fund the launch of a new Affordable Care Act offering for federal and state exchanges. Sidecar Health's model proved successful with early membership, with healthcare providers enthusiastically adopting the upfront cash pricing approach, as providers set their own cash prices and benefit from rapid payment while members gain price transparency for shopping and decision-making.
Jul 2020Series BCathay Innovation (lead); Kauffman Fellows; GreatPoint Ventures; Comcast Ventures; Morpheus Ventures; Anne Wojcicki$20M-Sidecar Health is a Los Angeles-based health insurtech company founded in 2018 that uses a cash-price model to provide transparent, affordable health insurance. The company enables members to access lower self-pay or cash prices directly from healthcare providers rather than using the higher rates negotiated by traditional insurance companies, powered by a proprietary app and payment technology that displays benefit amounts for over 170,000 medical services and prescription drugs before consumers access care. In July 2020, Sidecar Health closed a Series B funding round of $20 million led by Cathay Innovation, with participation from new investors Comcast Ventures, Kauffman Fellows, and 23andMe co-founder and CEO Anne Wojcicki, alongside existing backers GreatPoint Ventures and Morpheus Ventures. The funding brought the company's total raised to $40 million at that time and was designated for expanding to new geographies and growing the team at a moment when Coronavirus-related job losses had left an estimated 26.8 million people without employer-provided health insurance. The company's stated mission is to eliminate $1 trillion in healthcare waste annually by bringing transparency and consumer choice to the US healthcare market through its Visa payment card and mobile app platform. By January 2021, six months after this Series B round, Sidecar Health achieved a $1 billion valuation, and the company continued raising capital through subsequent Series C ($125M in 2023) and Series D ($165M in June 2024) rounds, accumulating $328 million in total funding by 2024.
Aug 2019Undisclosed stageGreatPoint Ventures (lead); Morpheus Ventures (lead); Alpha Edison$18M-Sidecar Health is a health insurtech company founded in 2018 that offers transparent, cash-pay health insurance plans allowing members to pay lower self-pay rates directly to providers, bypassing traditional insurance negotiations. The company uses an app for customizing coverage, price comparisons, and payments via a Visa card, targeting families, small businesses, and individuals seeking simplicity and savings of around 40% compared to conventional plans. Available in multiple states like Ohio, Georgia, Texas, and expanding nationwide, Sidecar focuses on employer plans, ACA offerings, and self-funded markets. In June 2019 (dated 06/08/2019 or 8/6/2019 in sources), Sidecar Health raised $18 million in a funding round led by GreatPoint Ventures and Morpheus Ventures, with participation from Alpha Edison among others. This appears to be a Series A round, following seed funding, aimed at building technology infrastructure, expanding member enrollment, and entering markets like Texas. GreatPoint Ventures has been a consistent backer across multiple rounds. Subsequent rounds built on this: $20 million Series B in July 2020 led by Cathay Innovation, Comcast Ventures, GreatPoint Ventures, Morpheus Ventures; $125 million Series C in January 2021 led by Drive Capital reaching $1 billion valuation; and $165 million Series D in June 2024 led by Koch Disruptive Technologies with GreatPoint Ventures and Morpheus Ventures participating. The company partnered with Mark Cuban Cost Plus Drug Company in 2024 for low-cost medications and secured Koch Industries as a client for workforce coverage.

Who has invested in Sidecar Health?

14 investors have backed Sidecar Health across its funding rounds, including GreatPoint Ventures, Cathay Innovation, Morpheus Ventures, Menlo Ventures, Drive Capital and Bond.

Lead investors include Koch Disruptive Technologies, Drive Capital, Cathay Innovation, GreatPoint Ventures and Morpheus Ventures.


Sidecar Health Investors

Investors in Sidecar Health by funding rounds participated
InvestorHQRoundsRoleFirst check
GreatPoint VenturesUnited StatesNew Haven, CT4LeadAug 2019
Morpheus VenturesUnited StatesLos Angeles, CA3LeadAug 2019
Cathay InnovationUnited StatesSan Francisco, CA3LeadJul 2020
Menlo VenturesUnited StatesSan Francisco, CA2ParticipantJan 2021
Alpha EdisonUnited StatesLos Angeles, CA2ParticipantAug 2019
Drive CapitalUnited StatesColumbus, OH2LeadJan 2021
BondUnited StatesSan Francisco, CA2ParticipantJan 2021
Kauffman FellowsUnited StatesSan Francisco, CA1ParticipantJul 2020
Comcast VenturesUnited StatesSan Francisco, CA1ParticipantJul 2020
Koch Disruptive TechnologiesUnited StatesWichita, KS1LeadJun 2024
MarbruckAustraliaSydney1ParticipantJun 2024
Tiger GlobalUnited StatesNew York City, NY1ParticipantJan 2021

This data is available for Pro users. Sign up to see all 14 Sidecar Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Sidecar Health Competitors

Sidecar Health competitors include listed companies like Trupanion and Hippo Insurance, and private ones like Acko, Clearcover, Branch and Ladder.

Public and private companies comparable to Sidecar Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
AckoIndiaMumbaiPrivate$303M-$1B3.3x
ClearcoverUnited StatesUnited StatesPrivate--$1B-
BranchUnited StatesColumbus, OHPrivate--$1.1B-
LadderUnited StatesSan Francisco, CAPrivate--$900M-
TrupanionUnited StatesUnited StatesPublicly listed$1.4B$39M$1.1B0.5x
Hippo InsuranceUnited StatesUnited StatesPublicly listed$469M$84M$844M1.2x

Sidecar Health Public Comps

Sidecar Health is still privately-owned, but its public comps include Sagicor Group Jamaica, Anadolu Hayat Emeklilik, Helia Group, Heritage Insurance, International General Insurance, Anadolu Sigorta, John Hancock, Capricorn Group, Chesnara and AgeSA.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Sagicor Group Jamaica$558M$153M1.8x-6.7x-
Anadolu Hayat Emeklilik$769M$170M1.1x1.5x4.9x-
Helia Group$288M$268M3.5x4.7x3.7x-
Heritage Insurance$774M$282M0.7x0.6x2.0x-
International General Insurance$525M$131M1.7x1.8x6.7x-
Anadolu Sigorta$1.9B$361M0.2x0.1x0.8x-
John Hancock$106M-12.5x---
Capricorn Group$342M-2.6x---

This data is available for Pro users. Sign up to see all Sidecar Health competitors and their valuation data.

Start Free Trial

Common questions about Sidecar Health

When was Sidecar Health founded?Sidecar Health was founded in 2018.
Where is Sidecar Health headquartered?Sidecar Health is headquartered in Los Angeles, CA, United States.
Is Sidecar Health publicly listed?No, Sidecar Health is a private, VC-backed company.
What is Sidecar Health's valuation?Sidecar Health was last valued at $1B in its Series C in January 2021.
How much funding has Sidecar Health raised?Sidecar Health has raised $328M across 4 funding rounds.
What was Sidecar Health's last funding round?Sidecar Health's last funding round was a $165M Series D in June 2024, led by Koch Disruptive Technologies.
Who are Sidecar Health's investors?Sidecar Health's investors include GreatPoint Ventures, Morpheus Ventures, Cathay Innovation, Menlo Ventures, Alpha Edison, Drive Capital, Bond, Kauffman Fellows, Comcast Ventures, Koch Disruptive Technologies and 4 others.
Which companies are comparable to Sidecar Health?Companies comparable to Sidecar Health include Acko, Clearcover, Branch, Ladder, Trupanion and Hippo Insurance.

See companies similar to Sidecar Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial